Rheumnow Podcast

Join Drs. Jack Cush, Alfred Kim, Janet Pope, and Yuz Yusof for a focused conversation on the latest in CAR-T from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what's shaping CAR-T practice right now.

Join Drs. Jack Cush, Peter Nash, Antoni Chan, and Nelly Ziade for an expert discussion on the most important psoriatic arthritis developments emerging from EULAR 2026.

This focused conversation explores new clinical data, evolving treatment strategies, and practical approaches to managing PsA in everyday practice. From advances in biologic and targeted therapies to ongoing challenges in diagnosis, disease monitoring, and patient care, the panel shares key insights and take-home messages that every rheumatology clinician should know.

Tune in for expert perspectives, clinical pearls, and a comprehensive look at what's shaping the future of psoriatic arthritis management.

2026 EULAR Preview
Beyond BMI: Altered Body Composition in Rheumatoid Arthritis
CAR-T For Rheumatoid Arthritis
This Is a Woman’s World: Women's Health in Rheumatic Disease
Low dose Blinatumomab: Many Relapse with an Unexpected Surprise
Doctor's Orders or Patient's Choice: BACH study findings
Another Way to Leverage NK Cells to Kill B Cells, This Time Without CARs
Digital Patient Education in RA
Making Methotrexate More Effective
Are we failing in the treatment of RA-ILD?
Using AI to Predict Progression to RA
Treat to Target Works in Elderly Onset RA
RA BRIDGE and RA BRANCH trials: Baricitinib and VTE Risk
Improving Referrals for Inflammatory Arthritis
Combination Therapy: Off the Shelf Allogenic NK and Rituximab in Rheumatic Disease

2026 EULAR Preview
Imaging in Subclinical Psoriatic Arthritis
Dietary Interventions in PsA
This Is a Woman’s World: Women's Health in Rheumatic Disease
Impact of Synovial Biopsy-Driven Therapeutic Stratification in PsA
Can We Stop PsA Before it Starts?
BE BOLD: Going Where No PsA Trial Has Gone Before
BMI Outranks Treatment in PsA Outcomes?
Debate: Combination Therapies for Inflammatory Arthritis?
Combination Biologics in PsA: MRI Findings from AFFINITY
Combination Therapy in SpA
The Case for Dual Pathway Blockade in Refractory PsA
The AFFINITY Study: Combination Treatment in PsA
PsA Potpourri: Probiotics & Head-to-Head Data
Transition from Psoriasis to Psoriatic Arthritis
MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsA
Guselkumab Delivers Across the PsA Disease Spectrum: APEX Trial

2026 EULAR Preview
CAR-T For Rheumatoid Arthritis
What Happens when CAR-T Fails Managing Disease Recurrence
Management of Relapses After CAR-T Therapy in SLE, SSc and IIM
How Many CAR-Ts Do We Need to Test Drive?